Regulatory bodies like the FDA or the European Medicines Agency (EMA) have stringent guidelines to oversee compassionate use programs. They ensure that:
- The patient's health and safety are prioritized. - The investigational drug is provided in a controlled and ethical manner. - Data is collected to monitor the drug's effects and inform future research.
